We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vaping Expected to Increase COPD Health and Economic Burden by 2050 New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in...
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence...
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis 36,000 people across 17 markets responded to the company’s fourth annual survey.40% of respondents get no more than three...
ResMed Adopts New Operating Model to Accelerate Long-term Growth Justin Leong appointed Chief Product Officer, effective immediately.Katrin Pucknat appointed Chief Marketing Officer...
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software Expands ResMed’s sleep management software solution, will help sleep labs and physicians more...
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP The studies also showed 18-40% lower costs incurred from ER...
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023 France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP...
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer Rider and Haake, both internal promotions, joined ResMed’s executive team on May...
ResMed Chief Administrative Officer and Global General Counsel to Retire ResMed to conduct an internal search for a successor general counselAmy Wakeham appointed Chief Communications and...
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep 81% of respondents experience one or more symptoms indicating poor...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 102.85 | 102.85 | 102.85 | 184 | 102.85 | DE |
4 | 0 | 0 | 102.85 | 102.85 | 102.85 | 1193 | 102.85 | DE |
12 | 0 | 0 | 102.85 | 102.85 | 102.85 | 1004 | 102.85 | DE |
26 | 0 | 0 | 102.85 | 102.85 | 102.85 | 1221 | 102.85 | DE |
52 | 0 | 0 | 102.85 | 102.85 | 102.85 | 1262 | 102.85 | DE |
156 | 0 | 0 | 102.85 | 102.85 | 102.85 | 1699 | 102.85 | DE |
260 | 0 | 0 | 102.85 | 102.85 | 102.85 | 1245 | 102.85 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions